Table: Statistical report of clinical cases treated by the Wu medical team from 2005 to 2013
| Diseases & Disorders |
Country |
* Improvement % |
** Significant Improvement% |
Total Cases Treated
2,670 |
China: 31% Overseas: 69% |
89% (2,377) |
73% (1953) |
Stroke
597 |
China: 53% Overseas: 47% |
97% (579) |
89% (531) |
Parkinson’s Disease
429 |
China: 24% Overseas: 66% |
96% (412) |
92% (395) |
Cerebral Palsy
256 |
China: 27% Overseas: 73% |
96% (246) |
89% (228) |
Brain Damage/Injury
206 |
China: 51% Overseas: 49% |
95% (196) |
72% (148) |
Amyotrophic Lateral Sclerosis (ALS)
149 |
China: 12% Overseas: 88% |
89% (133) |
53% (79) |
Spinal Cord Injury
132 |
China: 45% Overseas: 55% |
88% (116) |
38% (50) |
Retinitis Pigmentosa & Optic Nerve Disease
112 |
China:21% Overseas: 79% |
92% (39) |
68%(29) |
Encephalitis/Myelitis Sequela
101 |
China: 46% Overseas:54% |
91%(91) |
56%(56) |
Multiple System Atrophy (MSA)
89 |
China: 21% Overseas:79% |
92% (82 |
67% (59) |
Epilepsy
89 |
China:60% Overseas: 40% |
80% (23) |
60% (17) |
Multiple Sclerosis (MS)
85 |
China: 36% Overseas: 64% |
92% (78) |
58% (49) |
Ataxia
75 |
China: 33% Overseas: 67% |
89%(67) |
67%(50) |
Rheumatism and Rheumatoid Disease
51 |
China:30% Overseas: 70% |
92% (47) |
84% (43) |
Spinal Muscular Atrophy (SMA)
42 |
China: 28% Overseas: 72% |
83%(35) |
62%(26) |
Autism
42 |
China:20% Overseas: 80% |
95% (40) |
76% (32) |
Diabetes (Types 1 & 2)
40 |
China:50% Overseas: 50% |
96%(27) |
90%(25) |
Batten’s Disease
37 |
China: 15% Overseas: 85% |
79% (29) |
45% (17) |
Muscular Dystrophy/Polymyositis
32 |
China: 18% Overseas: 82% |
94% (30) |
80% (26) |
Huntington’s Disease
25 |
China:20% Overseas: 80% |
92% (23) |
69% (17) |
Renal Insufficiency
18 |
China:35% Overseas: 65% |
87% (26) |
87% (26) |
Other
63 |
China:56% Overseas: 44% |
92% (58) |
80% (50) |
*: Function restored by 20-30%; Function restored > 30%;
**: Total rate of improvement: 89%; Total rate of significant improvement: 73% | 
